🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The scope of GALILEO project (Genomic ALteratIons and cLonal EvOlution in A...
Status
Unknown
Location
Fondazione Policlinico Gemelli IRCCS
Start Date
2021-07-12
Trial ID
NCT06234579
Treatments Being Tested
This is a phase 2/3, global, multicenter, open-label, multi-cohort study de...
Status
Active Not Recruiting
Location
UC Davis
Start Date
2017-09-22
Trial ID
NCT03178552
This study aims to explore for the first time how the different ALK TKIs ha...
Status
Completed
Location
Pfizer Innovations AB
Start Date
2020-12-14
Trial ID
NCT04647110
Treatments Being Tested
This research study is evaluating two drugs, alectinib and bevacizumab, as ...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2015-09-28
Trial ID
NCT02521051
Treatments Being Tested
This clinical trial is looking at a drug called alectinib. Alectinib is app...
Status
Recruiting
Location
Belfast City Hospital
Start Date
2023-12-18
Trial ID
NCT05770037
Treatments Being Tested
The primary purpose of this study is to determine the differences in PFS fo...
Status
Completed
Location
EmpiraMed, Inc.
Start Date
2018-07-23
Trial ID
NCT03546894
Treatments Being Tested
This interventional study aims to determine the pharmacokinetics of orally ...
Status
Recruiting
Location
Thoracic Oncology Unit and Personalized Medicine Laboratory, Instituto Nacional de Cancerología
Start Date
2022-05-01
Trial ID
NCT05713006
Treatments Being Tested
DETERMINE is an open-label phase II/III trial. It will look at targeted tre...
Status
Recruiting
Location
Belfast City Hospital
Start Date
2023-03-01
Trial ID
NCT05722886
This National Cancer Institute (NCI)-NRG ALK Protocol phase II trial studie...
Status
Terminated
Location
CTCA at Western Regional Medical Center
Start Date
2019-07-25
Trial ID
NCT03737994
Treatments Being Tested
This study will evaluate the efficacy and safety of alectinib in participan...
Status
Terminated
Location
Science 37, Inc
Start Date
2021-05-24
Trial ID
NCT04644315
Treatments Being Tested